North America Ophthalmic Clinical Trials Market Recent Developments, Company Analysis, and Strategic Key Takeaways
Payal Rabde is a Market Research Analyst specializing in the healthcare, pharmaceuticals, biotechnology, and life science market. She tracks increasing clinical activities, expanding retinal disease treatments, and new platform launches. Her research provides in-depth market intelligence, competitive analysis, and strategic insights to support ophthalmic clinical trials growth across North America. She also highlighted that the Izervay GATHER1 and GATHER2 trials resulted in a 17.4% and 18% reduction, respectively, in the mean rate of GA lesion growth vs sham.
Last Updated : 07 September 2026
Category: Healthcare Services
Insight Code: 7058
Format: PDF / PPT / Excel